Heightened JNK Activation and Reduced XIAP Levels Promote TRAIL and Sunitinib-Mediated Apoptosis in Colon Cancer Models.

Mahalingam, Devalingam; Carew, Jennifer S; Espitia, Claudia M; Cool, Robbert H; Giles, Francis J; de Jong, Steven; Nawrocki, Steffan T.

Afiliação

Mahalingam D; Department of Medicine, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL 60611, USA. Mahalingam@nm.org.
Carew JS; Department of Medicine, University of Arizona Cancer Center, Tucson, AZ 85724, USA. jcarew@email.arizona.edu.
Espitia CM; Department of Medicine, University of Arizona Cancer Center, Tucson, AZ 85724, USA. espitiac@email.arizona.edu.
Cool RH; Department of Chemical and Pharmaceutical Biology, Groningen Research Institute of Pharmacy (GRIP), University of Groningen, 9713 GZ Groningen, The Netherlands. r.h.cool@rug.nl.
Giles FJ; Department of Medicine, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL 60611, USA. Frankgiles@aol.com.
de Jong S; Department of Medical Oncology, University Medical Centre Groningen, University of Groningen, 9713 GZ Groningen, The Netherlands. s.de.jong@umcg.nl.
Nawrocki ST; Department of Medicine, University of Arizona Cancer Center, Tucson, AZ 85724, USA. snawrocki@email.arizona.edu.

Cancers (Basel) ; 11(7)2019 Jun 26.

Article em En | MEDLINE | ID: mdl-31248045